• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大肠杆菌O111的一种表面多糖含有O抗原,并能抑制O抗血清对细胞的凝集作用。

A surface polysaccharide of Escherichia coli O111 contains O-antigen and inhibits agglutination of cells by O-antiserum.

作者信息

Goldman R C, White D, Orskov F, Orskov I, Rick P D, Lewis M S, Bhattacharjee A K, Leive L

出版信息

J Bacteriol. 1982 Sep;151(3):1210-21. doi: 10.1128/jb.151.3.1210-1221.1982.

DOI:10.1128/jb.151.3.1210-1221.1982
PMID:6179923
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC220398/
Abstract

The repeating pentasaccharide of O-antigen from Escherichia coli O111 contains galactose, glucose, N-acetylglucosamine, and colitose, the latter representing the major antigenic determinant. Phenol extraction of this strain was previously shown to release two fractions (I and II) containing O-antigen carbohydrate, and both fractions were believed to be lipopolysaccharide. We have now characterized fractions I and II and conclude that only fraction II represents lipopolysaccharide. Fraction II contains phosphate, 2-keto-3-deoxyoctonate, beta-hydroxymyristic acid, and potent endotoxin activity, whereas fraction I was deficient in all of these properties of the lipid A and core oligosaccharide regions of lipopolysaccharide. Fractions I and II each represented 50% of the total cellular O-antigen, and both were present on the cell surface. Both fractions were metabolically stable, and no precursor-product relationship existed between them. Fraction II had a number-average molecular weight of 15,800, corresponding to an average of 12 O-antigen repeats per molecule. In contrast, fraction I had a number-average molecular weight of 354,000, corresponding to an average of 404 O-antigen repeats per molecule. Before heat treatment, cells of E. coli O111 are poorly agglutinated by O-serum; although this indicates the presence of a capsule, the corresponding K-antigen was never detected. We conclude that fraction I, when present on the cell surface, inhibits agglutination of unheated cultures of E. coli O111 by O-serum because: (i) a variant strain which lacks fraction I was agglutinated by O-serum without prior heating; (ii) erythrocytes coated with purified fraction I behaved like bacteria containing fraction I in showing inhibition of O-serum agglutination; and (iii) heat treatment released fraction I and rendered bacterial cells agglutinable in O-serum.

摘要

大肠杆菌O111的O抗原重复五糖包含半乳糖、葡萄糖、N-乙酰葡糖胺和可立糖,后者是主要的抗原决定簇。先前已表明,对该菌株进行苯酚提取可释放出两个含有O抗原碳水化合物的组分(I和II),并且这两个组分都被认为是脂多糖。我们现在已对组分I和II进行了表征,并得出结论,只有组分II代表脂多糖。组分II含有磷酸盐、2-酮-3-脱氧辛酸、β-羟基肉豆蔻酸和强效内毒素活性,而组分I在脂多糖的脂质A和核心寡糖区域的所有这些特性方面均有欠缺。组分I和II各占细胞总O抗原的50%,且二者均存在于细胞表面。这两个组分在代谢上均稳定,且它们之间不存在前体-产物关系。组分II的数均分子量为15,800,相当于每个分子平均有12个O抗原重复序列。相比之下,组分I的数均分子量为354,000,相当于每个分子平均有404个O抗原重复序列。在热处理之前,大肠杆菌O111细胞被O血清凝集的能力较差;尽管这表明存在荚膜,但从未检测到相应的K抗原。我们得出结论,当组分I存在于细胞表面时,它会抑制O血清对未加热的大肠杆菌O111培养物的凝集,原因如下:(i)缺乏组分I的变异菌株在未经预先加热的情况下可被O血清凝集;(ii)涂有纯化组分I的红细胞在表现出对O血清凝集的抑制方面与含有组分I的细菌相似;(iii)热处理释放了组分I并使细菌细胞在O血清中可被凝集。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b31b/220398/51eb76153221/jbacter00256-0157-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b31b/220398/98971b47386f/jbacter00256-0155-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b31b/220398/51eb76153221/jbacter00256-0157-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b31b/220398/98971b47386f/jbacter00256-0155-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b31b/220398/51eb76153221/jbacter00256-0157-a.jpg

相似文献

1
A surface polysaccharide of Escherichia coli O111 contains O-antigen and inhibits agglutination of cells by O-antiserum.大肠杆菌O111的一种表面多糖含有O抗原,并能抑制O抗血清对细胞的凝集作用。
J Bacteriol. 1982 Sep;151(3):1210-21. doi: 10.1128/jb.151.3.1210-1221.1982.
2
Serum-resistant mutants of Escherichia coli O111 contain increased lipopolysaccharide, lack an O antigen-containing capsule, and cover more of their lipid A core with O antigen.大肠杆菌O111的血清抗性突变体含有增加的脂多糖,缺乏含O抗原的荚膜,并且其脂质A核心更多地被O抗原覆盖。
J Bacteriol. 1984 Sep;159(3):877-82. doi: 10.1128/jb.159.3.877-882.1984.
3
Immunological studies of a heterogenetic enterobacterial antigen (Kunin).一种异源性肠道细菌抗原(库宁)的免疫学研究
J Bacteriol. 1962 Dec;84(6):1245-50. doi: 10.1128/jb.84.6.1245-1250.1962.
4
A simple procedure to demonstrate the presence of the O-antigen capsule in enteropathogenic Escherichia coli.一种用于证明肠致病性大肠杆菌中O抗原荚膜存在的简单程序。
Zentralbl Bakteriol. 1994 Aug;281(2):140-5. doi: 10.1016/s0934-8840(11)80564-5.
5
Antigenic and immunogenic differences in lipopolysaccharides of Escherichia coli J5 vaccine strains of different origins.
J Gen Microbiol. 1993 Nov;139(11):2641-7. doi: 10.1099/00221287-139-11-2641.
6
Comparative immunogenicity of conjugates composed of Escherichia coli O111 O-specific polysaccharide, prepared by treatment with acetic acid or hydrazine, bound to tetanus toxoid by two synthetic schemes.通过两种合成方案将经乙酸或肼处理制备的大肠杆菌O111 O特异性多糖与破伤风类毒素结合而成的缀合物的比较免疫原性。
Infect Immun. 1995 Aug;63(8):2805-10. doi: 10.1128/iai.63.8.2805-2810.1995.
7
Polysaccharide antigens of Escherichia coli.大肠杆菌的多糖抗原
Rev Infect Dis. 1987 Sep-Oct;9 Suppl 5:S517-26. doi: 10.1093/clinids/9.supplement_5.s517.
8
Studies on hemagglutination and hemolysis by escherichia coli antisera.大肠杆菌抗血清的血凝和溶血研究。
J Exp Med. 1952 Jul;96(1):1-15. doi: 10.1084/jem.96.1.1.
9
Role of the rfe gene in the biosynthesis of the Escherichia coli O7-specific lipopolysaccharide and other O-specific polysaccharides containing N-acetylglucosamine.rfe基因在大肠杆菌O7特异性脂多糖及其他含N-乙酰葡糖胺的O特异性多糖生物合成中的作用。
J Bacteriol. 1994 Nov;176(22):7079-84. doi: 10.1128/jb.176.22.7079-7084.1994.
10
[Somatic antigens of Shigella and Escherichia coli. Determination of the structure of O-specific polysaccharide from Shigella boydii type 12 and its serological properties compared with the O-specific polysaccharide from Escherichia coli].[志贺氏菌和大肠杆菌的体细胞抗原。12型鲍氏志贺氏菌O特异性多糖结构的测定及其与大肠杆菌O特异性多糖的血清学特性比较]
Bioorg Khim. 1986 Sep;12(9):1240-52.

引用本文的文献

1
New l-Rhamnose-Binding Lectin from the Bivalve : Purification, Partial Structural Characterization and Antibacterial Activity.来自双壳贝类的新型 l-鼠李糖结合凝集素:纯化、部分结构特征和抗菌活性。
Mar Drugs. 2023 Dec 29;22(1):27. doi: 10.3390/md22010027.
2
Capsules and Extracellular Polysaccharides in Escherichia coli and Salmonella.大肠杆菌和沙门氏菌中的胶囊和细胞外多糖。
EcoSal Plus. 2021 Dec 15;9(2):eESP00332020. doi: 10.1128/ecosalplus.ESP-0033-2020. Epub 2021 Dec 1.
3
Escherichia coli O127 group 4 capsule proteins assemble at the outer membrane.

本文引用的文献

1
Escherichia strains from infantile epidemic gastro enteritis.来自婴儿流行性肠胃炎的大肠杆菌菌株。
Acta Pathol Microbiol Scand. 1950;27(4):552-64. doi: 10.1111/j.1699-0463.1950.tb04927.x.
2
THE BIOSYNTHESIS OF CELL WALL LIPOPOLYSACCHARIDE IN ESCHERICHIA COLI. I. THE BIOCHEMICAL PROPERTIES OF A URIDINE DIPHOSPHATE GALACTOSE 4-EPIMERASELESS MUTANT.大肠杆菌细胞壁脂多糖的生物合成。I. 一种尿苷二磷酸半乳糖4-表异构酶缺失突变体的生化特性。
J Biol Chem. 1965 May;240:1919-25.
3
THE RELEASE OF RIBONUCLEASE INTO THE MEDIUM WHEN ESCHERICHIA COLI CELLS ARE CONVERTED TO SPEROPLASTS.
大肠杆菌 O127 组 4 荚膜蛋白在细胞膜组装。
PLoS One. 2021 Nov 15;16(11):e0259900. doi: 10.1371/journal.pone.0259900. eCollection 2021.
4
Genomic diversity and organization of complex polysaccharide biosynthesis clusters in the genus Dickeya.迪克氏菌属中复杂多糖生物合成簇的基因组多样性和组织。
PLoS One. 2021 Feb 11;16(2):e0245727. doi: 10.1371/journal.pone.0245727. eCollection 2021.
5
Evidence Suggesting That Francisella tularensis O-Antigen Capsule Contains a Lipid A-Like Molecule That Is Structurally Distinct from the More Abundant Free Lipid A.有证据表明,土拉弗朗西斯菌O抗原荚膜含有一种类脂A分子,其结构与更丰富的游离脂A不同。
PLoS One. 2016 Jun 21;11(6):e0157842. doi: 10.1371/journal.pone.0157842. eCollection 2016.
6
CD36 Differently Regulates Macrophage Responses to Smooth and Rough Lipopolysaccharide.CD36对巨噬细胞对光滑型和粗糙型脂多糖的反应有不同调控作用。
PLoS One. 2016 Apr 13;11(4):e0153558. doi: 10.1371/journal.pone.0153558. eCollection 2016.
7
The O-Antigen Capsule of Salmonella enterica Serovar Typhimurium Facilitates Serum Resistance and Surface Expression of FliC.肠炎沙门氏菌鼠伤寒血清型的O抗原荚膜促进血清抗性及鞭毛蛋白FliC的表面表达。
Infect Immun. 2015 Oct;83(10):3946-59. doi: 10.1128/IAI.00634-15. Epub 2015 Jul 20.
8
A universal polysaccharide conjugated vaccine against O111 E. coli.一种通用的 O111 大肠杆菌多糖共轭疫苗。
Hum Vaccin Immunother. 2014;10(10):2864-74. doi: 10.4161/21645515.2014.972145. Epub 2014 Nov 21.
9
A hybrid cationic peptide composed of human β-defensin-1 and humanized θ-defensin sequences exhibits salt-resistant antimicrobial activity.一种由人β-防御素-1和人源化θ-防御素序列组成的杂合阳离子肽具有耐盐抗菌活性。
Antimicrob Agents Chemother. 2015 Jan;59(1):217-25. doi: 10.1128/AAC.03901-14. Epub 2014 Oct 27.
10
Both group 4 capsule and lipopolysaccharide O-antigen contribute to enteropathogenic Escherichia coli resistance to human α-defensin 5.组 4 荚膜和脂多糖 O 抗原都有助于肠致病性大肠杆菌对人防御素 5 的抗性。
PLoS One. 2013 Dec 4;8(12):e82475. doi: 10.1371/journal.pone.0082475. eCollection 2013.
大肠杆菌细胞转化为原生质体时核糖核酸酶释放到培养基中的情况。
J Biol Chem. 1964 Nov;239:3893-900.
4
ORIGIN AND PROPERTIES OF NATURALLY OCCURRING HAPTEN FROM ESCHERICHIA COLI.来自大肠杆菌的天然存在半抗原的起源与特性
J Bacteriol. 1964 Dec;88(6):1705-20. doi: 10.1128/jb.88.6.1705-1720.1964.
5
EQUILIBRIUM ULTRACENTRIFUGATION OF DILUTE SOLUTIONS.稀溶液的平衡超速离心法
Biochemistry. 1964 Mar;3:297-317. doi: 10.1021/bi00891a003.
6
Estimation of 3-deoxy sugars by means of the malonaldehyde-thiobarbituric acid reaction.通过丙二醛 - 硫代巴比妥酸反应对3 - 脱氧糖进行测定。
Nature. 1960 Apr 9;186:155-6. doi: 10.1038/186155a0.
7
Production of O inagglutinability in erythrocytes coated with typhoid Vi and O antigens.伤寒Vi和O抗原包被的红细胞中O不凝集性的产生。
Nature. 1955 Dec 31;176(4496):1266-7. doi: 10.1038/1761266a0.
8
[A micro-method of immuno-electrophoresis].[免疫电泳的微量方法]
Int Arch Allergy Appl Immunol. 1955;7(2):103-10.
9
Identification of outer membrane proteins, including known lymphocyte mitogens, as the endotoxin protein of Escherichia coli 0111.鉴定包括已知淋巴细胞促细胞分裂剂在内的外膜蛋白为大肠杆菌0111的内毒素蛋白。
J Immunol. 1981 Oct;127(4):1290-4.
10
Lipid on capsular polysaccharides of gram-negative bacteria.革兰氏阴性菌荚膜多糖上的脂质。
J Biol Chem. 1981 Sep 10;256(17):8915-21.